A genome-wide association study identifies novel risk loci for type 2 diabetes

Nature

Volumn 445, Issue 7130, 2007, Pages 881-885

  Sladek, Robert ^a,b,c   Rocheleau, Ghislain ^a   Rung, Johan ^c   Dina, Christian ^d   Shen, Lishuang ^a   Serre, David ^a   Boutin, Philippe ^d   Vincent, Daniel ^c   Belisle, Alexandre ^c   Hadjadj, Samy ^e   Balkau, Beverley ^f   Heude, Barbara ^f   Charpentier, Guillaume ^g   Hudson, Thomas J ^c,h   Montpetit, Alexandre ^c   Pshezhetsky, Alexey V ⁱ   Prentki, Marc ^i,j,k   Posner, Barry I ^b,l   Balding, David J ^m   Meyre, David ^d   Polychronakos, Constantin ^a,b   Froguel, Philippe ^d,m,n   more..

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d INSTITUT PASTEUR DE LILLE   (France)

^e POITIERS UNIVERSITY HOSPITAL   (France)

^f INSERM   (France)

^g CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^h ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

ⁱ Montreal Diabetes Research Center   (Canada)

^j UNIVERSITY OF MONTREAL   (Canada)

^k UNIVERSITÉ DE MONTRÉAL   (Canada)

^l Polypeptide Hormone Laboratory   (Canada)

^m IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁿ HAMMERSMITH HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALX4 PROTEIN; EXOSTOSIN 2; GENE PRODUCT; HOMEODOMAIN PROTEIN; INSULINASE; KINESIN INTERACTING FACTOR 11; SLC30A8 PROTEIN; TCF7L2 PROTEIN; UNCLASSIFIED DRUG; ZINC TRANSPORTER;

COHORT ANALYSIS; DIABETES; GENE EXPRESSION; GENETIC MARKER; GENETIC VARIATION; GENOME; GENOTYPE; HEALTH RISK; POLYMORPHISM;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FRANCE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 8; DIABETES MELLITUS, TYPE 2; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LINKAGE DISEQUILIBRIUM;

EURASIA; EUROPE; FRANCE; WESTERN EUROPE;

EID: 33847176604     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature05616     Document Type: Article

References (50)

1. Permutt, M. A., Wasson, J. & Cox, N. Genetic epidemiology of diabetes. J. Clin. Invest. 115, 1431-1439 (2005).
2. Horikawa, Y. et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nature Genet. 26, 163-175 (2000).
3. Meyre, D. et al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nature Genet. 37, 863-867 (2005).
4. Love-Gregory, L. D. et al. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4α gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi jewish population. Diabetes 53, 1134-1140 (2004).
5. Silander, K. et al. Genetic variation near the hepatocyte nuclear factor-4α gene predicts susceptibility to type 2 diabetes. Diabetes 53, 1141-1149 (2004).
6. Vasseur, F. et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum. Mol. Genet. 11, 2607-2614 (2002).
7. Altshuler, D. et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genet. 26, 76-80 (2000).
8. ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52, 568-572 (2003).
9. Grant, S. F. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genet. 38, 320-323 (2006).
10. Zhang, C. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men. Diabetes 55, 2645-2648 (2006).
11. Damcott, C. M. et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 55, 2654-2659 (2006).
12. Scott, L. J. et al. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 55, 2649-2653 (2006).
13. Groves, C. J. et al. Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 55, 2640-2644 (2006).
14. Cauchi, S. et al. TCF7L2 variation predicts hyperglycemia incidence in a French general population: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. Diabetes 55, 3189-3192 (2006).
15. Chandak, G. R. et al. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia 50, 63-67 (2007).
16. Florez, J. C. et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med. 355, 241-250 (2006).
17. Humphries, S. E. et al. Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European whites, Indian Asians and Afro-Caribbean men and women. J. Mol. Med. 84, 1-10 (2006).
18. Parton, L. E. et al. Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis. Am. J. Physiol. Endocrinol. Metab. 291, E982-E994 (2006).
19. Saxena, R. et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55, 2890-2895 (2006).
20. Weedon, M. N. et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 3, e374 (2006).
21. Fingerlin, T. E., Boehnke, M. & Abecasis, G. R. Increasing the power and efficiency of disease-marker case-control association studies through use of allele-sharing information. Am. J. Hum. Genet. 74, 432-443 (2004).
22. Balkau, B. An epidemiologic survey from a network of French Health Examination Centres, (D.E.S.I.R.): epidemiologic data on the insulin resistance syndrome. Rev. Epidemiol. Sante Publique 44, 373-375 (1996).
23. International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
24. Campbell, C. D. et al. Demonstrating stratification in a European American population. Nature Genet. 37, 868-872 (2005).
25. Chimienti, F. et al. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J. Cell Sci. 119, 4199-4206 (2006).
26. Duggirala, R. et al. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am. J. Hum. Genet. 64, 1127-1140 (1999).
27. Ghosh, S. et al. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am. J. Hum. Genet. 67, 1174-1185 (2000).
28. Meigs, J. B., Panhuysen, C. I., Myers, R. H., Wilson, P. W. & Cupples, L. A. A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes 51, 833-840 (2002).
29. Wiltshire, S. et al. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am. J. Hum. Genet. 69, 553-569 (2001).
30. Bort, R., Martinez-Barbera, J. P., Beddington, R. S. & Zaret, K. S. Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas. Development 131, 797-806 (2004).
31. Bort, R., Signore, M., Tremblay, K., Martinez Barbera, J. P. & Zaret, K. S. Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. Dev. Biol. 290, 44-56 (2006).
32. Foley, A. C. & Mercola, M. Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex. Genes Dev. 19, 387-396 (2005).
33. Bennett, R. G., Hamel, F. G. & Duckworth, W. C. An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures. Diabetes 52, 2315-2320 (2003).
34. Farris, W. et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc. Natl Acad. Sci. USA 100, 4162-4167 (2003).
35. Groves, C. J. et al. Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. Diabetes 52, 1300-1305 (2003).
36. Karamohamed, S. et al. Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes 52, 1562-1567 (2003).
37. Florez, J. C. et al. High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people. Diabetes 55, 128-135 (2006).
38. Apelqvist, A., Ahlgren, U. & Edlund, H. Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas. Curr. Biol. 7, 801-804 (1997).
39. Thomas, M. K., Rastalsky, N., Lee, J. H. & Habener, J. F. Hedgehog signaling regulation of insulin production by pancreatic β-cells. Diabetes 49, 2039-2047 (2000).
40. Boras-Granic, K., Grosschedl, R. & Hamel, P. A. Genetic interaction between Lef1 and Alx4 is required for early embryonic development. Int. J. Dev. Biol. 50, 601-610 (2006).
41. Di Rienzo, A. & Hudson, R. R. An evolutionary framework for common diseases: the ancestral-susceptibility model. Trends Genet. 21, 596-601 (2005).
42. Pritchard, J. K. Are rare variants responsible for susceptibility to complex diseases? Am. J. Hum. Genet. 69, 124-137 (2001).
43. Hallaq, H. et al. A null mutation of Hhex results in abnormal cardiac development, defective vasculogenesis and elevated Vegfa levels. Development 131, 5197-5209 (2004).
44. Stickens, D. et al. The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nature Genet. 14, 25-32 (1996).
45. Pritchard, J. K., Stephens, M. & Donnelly, P. Inference of population structure using multilocus genotype data. Genetics 155, 945-959 (2000).
46. Sasieni, P. D. From genotypes to genes: doubling the sample size. Biometrics 53, 1253-1261 (1997).
47. Clayton, D. G. et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nature Genet. 37, 1243-1246 (2005).
48. Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997-1004 (1999).
49. Reich, D. E. & Goldstein, D. B. Detecting association in a case-control study while correcting for population stratification. Genet. Epidemiol. 20, 4-16 (2001).
50. Kohler, K. & Bickeboller, H. Case-control association tests correcting for population stratification. Ann. Hum. Genet. 70, 98-115 (2006).